October 25th, 2004

Credited with absolute success, the events "Business Adaptability" and "Philip Kotler on Marketing" presented by the world known distinguished scientists Mr. Gary Hamel and Mr. Philip Kotler respectively, took place on the 21st and 22nd of October in Athens. Both events were sponsored by GENESIS Pharma.

The two analysts talks expanded on contemporary issues of current business reality). More specifically, Gary Hamel, "guru" in management and business strategy related issues, referred to the imperative need of organisations for a revolutionary restructuring, in strategic and administrative level, aiming at their adaptability within the new market conditions.

Numerous executives from the economic and business environment attended these two important events, in order to honor the famous lecturers. Participators, in total, made commendatory reference to the presence of topmost Gary Hamel and Philip Kotler in Athens, as well as to the topics discoursed during the events.

GENESIS Pharmas' sponsorship is part of a wide Corporate Social Responsibility program, carried by the company since its incorporation, revolving in the core areas of health, culture and corporate development. Mr. C. Evripides, GENESIS Pharma's CEO, stated: "Our goal has been achieved. We feel really honored when GENESIS Pharma is given the opportunity to support such successful events, which aggressively contribute to the faster, healthier and more constant growth of Greek companies".

GENESIS Pharma was incorporated in 1997, with the vision to substantially contribute to the treatment of life- threatening diseases. The company focuses on marketing, sales and distribution of specialised products emerging from biotechnology research for rare and chronic diseases. In reinforcing its role in the market, GENESIS Pharma has accomplished strategic alliances with top biopharmaceutical companies and has developed a strong regional presence in Greece and Southeast Europe. Today it represents top American and European companies of cellular and molecular technology such as Amgen, Biogen Idec, Chiron, Cephalon and Shire.